- Home
- RLAY vs MCBS Comparison
RLAY vs MCBS Comparison
Compare RLAY & MCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- MCBS
- Stock Information
- Founded
- RLAY 2015
- MCBS 2006
- Country
- RLAY United States
- MCBS United States
- Employees
- RLAY N/A
- MCBS N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- MCBS Major Banks
- Sector
- RLAY Health Care
- MCBS Finance
- Exchange
- RLAY Nasdaq
- MCBS Nasdaq
- Market Cap
- RLAY 803.4M
- MCBS 744.2M
- IPO Year
- RLAY 2020
- MCBS 2019
- Fundamental
- Price
- RLAY $6.22
- MCBS $26.64
- Analyst Decision
- RLAY Strong Buy
- MCBS Hold
- Analyst Count
- RLAY 8
- MCBS 1
- Target Price
- RLAY $17.25
- MCBS $34.00
- AVG Volume (30 Days)
- RLAY 1.7M
- MCBS 36.0K
- Earning Date
- RLAY 11-05-2025
- MCBS 10-17-2025
- Dividend Yield
- RLAY N/A
- MCBS 3.48%
- EPS Growth
- RLAY N/A
- MCBS 20.64
- EPS
- RLAY N/A
- MCBS 2.57
- Revenue
- RLAY $8,355,000.00
- MCBS $145,158,000.00
- Revenue This Year
- RLAY $27.33
- MCBS $18.90
- Revenue Next Year
- RLAY $7.40
- MCBS $30.18
- P/E Ratio
- RLAY N/A
- MCBS $10.28
- Revenue Growth
- RLAY N/A
- MCBS 14.81
- 52 Week Low
- RLAY $1.78
- MCBS $24.24
- 52 Week High
- RLAY $7.07
- MCBS $36.15
- Technical
- Relative Strength Index (RSI)
- RLAY 71.34
- MCBS 33.67
- Support Level
- RLAY $5.47
- MCBS $27.09
- Resistance Level
- RLAY $7.00
- MCBS $27.61
- Average True Range (ATR)
- RLAY 0.37
- MCBS 0.60
- MACD
- RLAY 0.11
- MCBS -0.17
- Stochastic Oscillator
- RLAY 70.90
- MCBS 14.26
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About MCBS MetroCity Bankshares Inc.
MetroCity Bankshares Inc is a holding company of its subsidiary Metro City Bank. It provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers and a variety of other banking services. The banks generate revenue from interest income. Its customers include small business owners, professionals, consumers, and real estate developers.